Update on cartilage oligomeric matrix protein as a marker of osteoarthritis

Journal of Rheumatology

Volumn 32, Issue 6, 2005, Pages 1145-1147

  Jordan, Joanne M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN FIBRIL; CORTICOSTEROID; ETANERCEPT; FIBRONECTIN; INFLIXIMAB; MATRILIN; PLACEBO; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; APOPTOSIS; ARTICULAR CARTILAGE; BLOOD LEVEL; BONE DYSPLASIA; CATABOLISM; CAUCASIAN; CONFERENCE PAPER; ENCHONDRAL OSSIFICATION; ENDOPLASMIC RETICULUM; ETHNIC DIFFERENCE; EXTRACELLULAR MATRIX; GENDER; HORMONE SUBSTITUTION; HUMAN; JOINT CAVITY; JOINT PROSTHESIS; NONHUMAN; OSTEOARTHRITIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN DEGRADATION; RHEUMATOID ARTHRITIS;

BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; ETHNIC GROUPS; EXTRACELLULAR MATRIX PROTEINS; GLYCOPROTEINS; HUMANS; OSTEOARTHRITIS; REFERENCE STANDARDS;

EID: 20444505993     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Mann HH, Ozbek S, Engel J, Paulsson M, Wagener R. Interactions between the cartilage oligomeric matrix protein and matrilins: Implications for matrix assembly and the pathogenesis of chondrodysplasias. J Biol Chem 2004;279:25294-8.
2. Johnson A, Smith R, Saxne T, Hickery M, Heinegard D. Fibronectin fragments cause release and degradation of collagen-binding molecules from equine explant cultures. Osteoarthritis Cartilage 2004;12:149-59.
3. Clark AG, Jordan JM, Vilim V, et al. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project. Arthritis Rheum 1999;42:2356-64.
4. Conrozier T, Saxne T, Fan CS, et al. Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study. Ann Rheum Dis 1998;57:527-32.
5. Sharif M, Kirwan JR, Elson CJ, Granell R, Clarke S. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years. Arthritis Rheum 2004;50:2479-88.
6. Jordan JM, Luta G, Stabler T, et al. Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein: the Johnston County Osteoarthritis Project. Arthritis Rheum 2003;48:675-81.
7. Bruyere O, Collette JH, Ethgen O, et al. Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis. J Rheumatol 2003;30:1043-50.
8. Dragomir AD, Jordan JM, Arab L, et al. Lower levels of serum cartilage oligomeric matrix protein in postmenopausal African-American and Caucasian women on current hormone replacement therapy [abstract]. Arthritis Rheum 2002;46 Suppl:S373.
9. Forsblad d'Elia H, Christgau S, Mattsson LA, et al. Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial. Arthritis Res Ther 2004;6:R457-R468.
10. Crnkic M, Mansson B, Larsson L, Geborek P, Heinegard D, Saxne T. Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept. Arthritis Res Ther 2003;5:R181-R185.
11. Larsson E, Erlandsson Harris H, Larsson A, Mansson B, Saxne T, Klareskog L. Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP. Rheumatology Oxford 2004;43:428-34.
12. Posey KL, Hayes E, Haynes R, Hecht JT. Role of TSP-5/COMP in pseudoachondroplasia. Int J Biochem Cell Biol 2004;36:1005-12.
13. Issack PS, Liu Cj, Prazak L, Di Cesare PE. A silencer element in the cartilage oligomeric matrix protein gene regulates chondrocyte-specific expression. J Orthop Res 2004;22:751-8.
14. Liu CJ, Prazak L, Fajardo M, Yu S, Tyagi N, DiCesare PE. Leukemia/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis. J Biol Chem 2004;279:47081-91.
15. Hecht JT, Makitie O, Hayes E, et al. Chondrocyte cell death and iritracellular distribution of COMP and type IX collagen in the pseudoachondroplasia growth plate. J Orthop Res 2004;22:759-67.